Pre-Clinical SIG Webinars
PSI Pre-clinical Special Interest Group has a
series of regular FREE webinars dealing with statistical topics faced in
pre-clinical and related fields. The presentations run for an hour, with
approximately 45 min presentation and a Q&A session in the remaining time.
See section below for details of this webinars. Please note that
these events take place online via Zoom, and have a limited number of places
available.
2025 Webinars
The PSI Pre-Clinical Special Interest Group seminars for 2025 are planned as follows:
Date | Title | Presenter | |
19 March 2025 | AI in Medicinal Products | Dr Liam Childs, AI working group lead - Paul Ehrlich Institute | To access video on demand, click here |
24 June 2025 | Methodology and first results of the iRISE (improving Reproducibility In SciencE) consortium | Rachel Heyard Postdoctoral Fellow at Center for Reproducible Science, University of Zurich
| To register, from April 28th, click here |
14 October 2025 | tbd | tbd |
|
2024 Webinars
The PSI Pre-Clinical Special Interest Group seminars for 2024 were as follows:
Date | Title | Presenter | |
26 March 2024 | Mixed-Level OMARS Designs for Quantitative and Categorical Factors: Theory and Application | Professor Peter Goos, KU Leuven | To access video on demand, click here |
8 October 2024 | Efficient R&D: SVEM and Advanced DOE in Preclinical Toxicity Testing | Phil Kay and Chandra Ramnarayanan, JMP | To access video on demand, click here |
26 November 2024 | Virtual Control Groups in Toxicity Studies
| Lea Vaas, Bayer
| To access video on demand, click here
|
Workshops
Workshop 2025, Verona
The Pre-Clinical Special Interest Group (SIG) Workshop 2025 will take place over two half-days on October 7–8 in Verona, Italy, bringing together experts from industry, academia, and regulatory institutions to discuss key challenges and innovations
in pre-clinical research.
This year’s workshop focuses on reproducibility, translatability, and methodological advancements in pre-clinical studies, with dedicated sessions on optimal study design, virtual control groups, and statistical tools like SAS and R. The agenda
includes invited presentations, interactive round table discussions, and ample opportunities for networking and collaboration, both during structured sessions and informal social events.
The event is designed to foster knowledge exchange, encourage cross-sector dialogue, and support the development of best practices in the evolving landscape of pre-clinical research.
Further details to come soon!
Workshop 2024, Paris
We held our first face-to-face workshop since 2019 in Paris this year. It was wonderful to connect with old and new faces.There was great engagement in the sessions; we all learnt something and had fun too!
Day | Title | Presenter(s) |
1 | Application of experimental design in animal research: theory and practice | Simon Bate, GSK |
2 | Analysing Pre-clinical experiments | Odile Coudert, Ipsen & Bernard Franq, GSK |
| Statistics in Toxicology | Philip Jarvis, Novartis & David Lovell, University of London |
